Review of high growth medical technologies, from Sept 2007 MedMarkets and the white paper of the same name.
MedMarket Diligence (MMD) founder Patrick Driscoll reviews obesity devices, and the overall obesity management market. From the August 2007 edition of MedMarkets and the September MMD report #S825, "Worldwide Market for the Clinical Management of Obesity, 2007."
Negative press on drug eluting stents have caused markets to negatively overreact, despite the persistence of demand for DES and predictable market patterns like this. From July 2007 MedMarkets by MedMarket Diligence.
The future of medical technology markets can be said to be defined by the technology focus of recent medtech startups.
Forces influencing medtech market success that have little to do with technology.
Review of developments, products, companies and dynamics in surgical sealants, glues and hemostasis. From the February 2007 MedMarkets and MedMarket Diligence report #S145.
Review of technologies, products and companies focused on applying ablation technologies for treatment of atrial fibrillation.
A review of embolic protection devices on the market and under development by device manufacturers. From December 2006 edition of MedMarkets.
The underlying underlying trends of medical technology startups identified by MedMarket Diligence in 2006.
From August 2006 MedMarket Outlook (MedMarkets) by MedMarket Diligence, Patrick Driscoll discussed the likely nature of advanced medtech devices, by comparison to the future of biotech options.